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Until 2006, it had appeared as if genital human papillomavirus (HPV) was an
unavoidable risk for sexually active men and women.  20 million people were already infected,
and approximately 6.2 million Americans stood to acquire the disease each year.   The Center for
1
Disease Control (CDC) estimated that by the age of 50, 80 percent of women will have
developed the infection.   While alarming in themselves, these numbers become even more
2
troubling when one considers the effects of genital HPV.  Approximately 10 out of the 30
identified types of genital HPV can lead to cervical cancer in women.   In rarer cases, HPV can
3
also cause cancers of the anus, vagina and vulva.   
4
Enter Gardasil.  In 2006, Merck Pharmaceuticals received approval from the Food and
Drug Administration (FDA) for its vaccine, Gardasil, which was developed, “to prevent cervical
cancer, precancerous genital lesions, and genital warts due to human papillomavirus.”   What
5
was hailed as a critical health measure and a “significant advance in the protection of women’s
Ctr. for Disease Control & Prevention, U.S. Dep't of Health & Human Servs., Genital
1
HPV Infection Fact Sheet 1 (2004), http://www.cdc.gov/std/HPV/hpv.pdf.
Id.
2
Id.
3
Ctr. for Disease Control & Prevention, U.S. Dep't of Health & Human Servs., HPV
4
Vaccine Information for Young Women,
http://www.cdc.gov/std/hpv/STDFact-HPV-vaccine-young-women.htm (last visited Mar. 29,
2009).
 Press Release, U.S. Food & Drug Admin., FDA Licenses New Vaccine for Prevention
5
of Cervical Cancer and Other Diseases in Females Caused by Human Papillomavirus: Rapid
Approval Marks Major Advancement in Public Health (June 8, 2006),
http://www.fda.gov/bbs/topics/NEWS/2006/NEW01385.html.
1health,”  quickly developed into a major legal and ethical controversy.  This controversy, pitting
6
those that claim Gardasil is ethically troubling against those who believe the vaccine should be
mandatory for all school-children, has recently intensified following Merck’s announcement that
it has completed clinical trials and is currently seeking FDA approval to use Gardasil to vaccinate
men.  
7
This paper will discuss the challenges that Merck will face in seeking societal and
governmental acceptance of an HPV vaccination for men.  Part I describes some of the
background of the HPV infection, in order to understand what lead Merck to develop the vaccine
in the first place.  Part II will discuss how the original Gardasil vaccine for women was
developed.  Part III explains the current status of the vaccine for men.  Part IV analyzes the
various barriers that Merck will face in convincing the public that men needs to be vaccinated
against HPV.  It breaks the opposition to the vaccine into two parts- Part A discusses the legal
barriers the vaccination will have to overcome, and Part B focuses on the ethical barriers. 
Finally, Part V speculates about the future of the Gardasil vaccine for men, and the options
Merck will have upon FDA approval.  
Part I: HPV Background
Genital HPV is a sexually transmitted disease which infects the skin of the penis, the
vulva (the area outside of the vagina), the anus, and the linings of the vagina, cervix, or rectum.  
8
Id.
6
Radha Chitale, Merck Hopes to Extend Gardasil Vaccine to Men, 101 Journal of the
7
National Cancer Institute Advance Access 222 (February 18, 2009).
Ctrs. for Disease Control & Prevention, supra note 1, at 1.
8
2Most people who are infected with the disease experience no symptoms.   While many are able to
9
clear the disease on their own, for others, it can develop into genital warts, or worse- the “high
risk” strains of the virus can lead to cervical, vulvar, or anal cancers if left undetected.   
10
HPV is spread primarily through genital contact.   Because the virus often has no
11
symptoms, infected individuals may infect their sex partners unknowingly.   While condom use
12
can be helpful in preventing the disease, it is not a foolproof method since the infection may
occur on parts of the male and female genitals that are not protected by a condom.   The CDC
13
recommends long-term, mutually monogamous relationships, although it acknowledges that even
these relationships may be susceptible to the infection since carriers are typically unaware that
they have the disease.   Another barrier to prevention of the disease is that at present, there are
14
no tests available to diagnose whether men carry the infection.  While women are able to be
diagnosed with HPV on the basis of abnormal Pap tests (cancer-screening tools which doctors
use to look for cervical cancer or pre-cervical cancer changes to the cervix) there are no such
screening tools for men.
15
The invention of Pap smear tests significantly reduced the risks of contracting cervical
Id.
9
Id.
10
Id.
11
Id.
12
Id. at 2.
13
Id. 
14
Id. at 1.
15
3cancer, since Pap tests can result in early detection of abnormalities caused by the cancer.  
16
Unfortunately, Pap smear tests are still not enough to deal with HPV on their own.  As discussed
above, HPV is still extremely common among sexually active adults.  This results in high
instances of cervical cancer, both in the United States and abroad.  The American Cancer Society
estimated that in 2008, approximately 11,070 cases of cervical cancer would be diagnosed in the
United States.  HPV is detected in 99% of cervical cancer cases.   Outside of the United States,
17 18
the numbers are even more startling.  Globally, 470,000 cases of cervical cancer are diagnosed
each year, resulting in approximately 230,000 deaths per year.    The prevalence of cervical
19
cancer abroad has been attributed to cultures who do not accept the Pap screening process, and
the lack of available resources to perform the test on those that do.   While cervical cancer has
20
been the obvious focus of much of the research surrounding HPV and the Gardasil vaccine,
homosexual men are also highly at risk for developing cancers related to HPV.  Gay and bisexual
men are reportedly 17 times more likely to develop anal cancer than their heterosexual
Id.
16
American Cancer Society, What are the Key Statistics About Cervical Cancer?, 
17
http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_cerv
ical_cancer_8.asp?sitearea= (last visited March 29, 2009).
Ctrs. for Disease Control & Prevention, U.S. Dep’t of Health & Human Servs.,
18
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory
Committee on Immunization Practices (ACIP), 56 Morbidity & Mortality Wkly. Rep.
1,2 (Mar. 23, 2007), available at http://www.cdc.gov/mmwr/PDF/rr/rr5602.pdf.
Kevin Outterson, Patent Buy-Outs for Global Disease Innovations for Low- and
19
Middle-Income Countries, 32 Am. J.L. & Med. 159, 164 (2006).
Richard Roden & T.-C. Wu, How Will HPV Vaccines Affect Cervical Cancer?, 6 Nature
20
Revs. Cancer 753, 753 (2006).
4counterparts.
21
Unfortunately, knowledge regarding HPV and its connection to cervical cancer is severely
lacking in the United States today.   A survey done by the National Cancer Institute’s Health
22
Information National Trends survey found that only 38.3% of women surveyed had even heard of 
HPV.   Less than 50% of these women knew that HPV caused cervical cancer. And while it is
23 24
certainly possibly to clear the infection without treatment, over 80% of those surveyed said that
they believed that HPV could not be cured without treatment.
25
Part II: Development of Gardasil
Vaccination is often the most cost-efficient method of combating an infectious disease
like HPV.   This understanding, along with the above-mentioned lack of knowledge regarding
26
the HPV infection, combined with the causal association with cervical cancer, the high incidence
of HPV throughout the population, and the inability to find an effective means to test for and
prevent the spread of HPV among sexually active individuals led Merck to develop the Gardasil
Emedtv.com, HPV in Men, http://hpv.emedtv.com/hpv/hpv-in-men.html (last visited
21
February 14, 2009)
Judith Sites-Poisson, Setting the Stage: Part One in a Series on the Politics and PR of
22
Cervical Cancer, CENTER FOR MEDIA & DEMOCRACY, June 26, 2007,
http://prwatch.org/node/6186.
Id.
23
Id.
24
Id.
25
Roden & Wu, supra note 20, at 753.
26
5vaccine.   The vaccine itself is made of self-assembled virus-like particles (VLPs), which closely
27
resemble native HPV particles and thus act as, “antigen[s] that evokes the production of HPV-
neutralizing antibodies in the human body.”   It was developed as a recombinant vaccine
28
(meaning it contains no live virus, like the measles or polio vaccines ), and it does not contain
29
DNA, so it is considered to be non-infectious.   It is administered via three injections over a six
30
month period.   Immunization is expected to prevent most cases of cervical cancer, although it
31
cannot protect women who were exposed to HPV before receiving the vaccine.   Merck
32
conducted four studies (one in the United States and three multinational) composed of 21,000
women between the ages of 16 to 26.   The results were overwhelmingly positive- although it
33
was not feasible to conduct the study for a long enough period of time to detect whether the
vaccine had prevented cervical cancer, according to the FDA, Gardasil was nearly 100 percent
effective in preventing precancerous cervical lesions, precancerous vaginal and vulvar lesions,
and genital warts.   Prevention of these precancerous lesions is considered indicative of
34
See L. Shi et al., Gardasil: Prophylactic Human Papillomavirus Vaccine Development-
27
From Bench Top to Bed-Side, 81 Clinical Pharmacology & Therapeutics 259, 261 (2007).
Amy L. Jonson, American Medical Ass’n Journal of Ethics, Development of the Human
28
Papillomavirus Vaccine and Guidelines for Its Use, 9 Virtual Mentor 30, 30-33 (January 2007).
VaccineInfo.net, Vaccine Facts: Conscientious Choice and Informed Consent for
29
Vaccination are Parental Rights, http://www.vaccineinfo.net/immunization/vaccine_facts.shtml
(last visited March 24, 2009).
See Jonson supra note 28.
30
Press Release, supra note 5. 
31
Id.
32
Id.
33
Id.
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6prevention of the later development of cervical cancer.   In September 2008, the FDA
35
announced its approval of Gardasil for use in preventing vulvar and vaginal cancers in addition to
cervical cancer.   Jesse L Goodman, the director of the FDA’s Center for Biologics Evaluation
36
and Research said, “There is now strong evidence showing that this vaccine can help prevent
vulvar and vaginal cancers...While [these] cancers are rare, the opportunity to help prevent them
is potentially an important additional benefit from immunization against HPV.”
37
The FDA approved Gardasil for use in females 9-26 years of age in June of 2006.   The
38
CDC’s Advisory Committee on Immunization Practices (ACIP) quickly followed,
recommending the vaccine for girls ages 11-12, but approved its use as early as age 9, and
extended it to females up to 26 years of age as well.   While there are no federal laws governing
39
the immunization of children, the ACIP consists of 15 members appointed by the U.S. Secretary
of the Department of Health and Human Services, and their recommendations become CDC
policy.   ACIP also resolved to include Gardasil in the Vaccination for Children (VFC) Program,
40
which provides free immunizations to many who are unable to afford vaccination on their own.  
41
Id.
35
Press Release, U.S. Food & Drug Admin., FDA Approves Expanded Uses for Gardasil
36
to Include Preventing Certain Vulvar and Vaginal Cancers (September 12, 2008),
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01885.html.
Id.
37
Press Release, supra note 5. 
38
Press Release, Office of Enter. Commc'n, Ctrs. for Disease Control & Prevention,
39
CDC's Advisory Committee Recommends Human Papillomavirus Virus Vaccination (June 29,
2006), http://www.cdc.gov/od/oc/media/pressrel/r060629.htm.
Id.
40
Sites-Poisson, supra note 22.
41
7Approximately 40-45% of the U.S. child population is covered by the VFC.
42
Following FDA and CDC approval, individual states began to regulate the use of Gardasil
for themselves, primarily through the use of school-entry mandatory vaccination laws.  These
laws allows the states to regulate the vaccine so it is given to pre-teens, since Gardasil is most
effective when it is given before the age of sexual debut.   In 2007, nearly half of high school
43
students reported having had sexual intercourse, and the median age of first intercourse typically
ranges from 17.4 for females, and 16.9 for males.   As a result, school-entry requirements for 11-
44
12 year olds seems to be the best way to reach students before they became sexually active in
high school.
In 2006, Michigan became the first state to introduce such legislation.    While the bill
45
was ultimately not enacted by the state legislature, many other states followed suit.   In Texas,
46
Governor Rick Perry bypassed the state legislature altogether by issuing an executive order
mandating that all girls become vaccinated before entering the sixth grade.   The executive
47
order, was supposed to have “saved legislators from having to go on record for or against a bill
Id.
42
See Roden and Wu, supra note 20, at 756 (Explaining that this protects young females
43
in the case of abuse or possible non-sexual transmission).
Kaiser Family Foundation, Sexual Health of Adolescents and Young Adults in the
44
United States 1 (September 2008), www.kff.org/womenshealth/upload/3040_04.pdf.
Nat'l Conference of State Legislatures, HPV Vaccine,
45
http://www.ncsl.org/programs/health/HPVvaccine.htm#hpvlegis (last visited March 29, 2009). 
Id.
46
Ralph Blumenthal, Texas Is First to Require Cancer Shots for Schoolgirls, N.Y. Times,
47
Feb. 3, 2007, at A9. 
8involving child sexuality.”   In May 2007, Virginia became the first state to successfully pass a
48
law mandating HPV vaccination for school attendance.   As of March 2009, at least 19 states
49
have passed some form of legislation to require, fund or educate the public about the HPV
vaccine.   
50
Part III: Getting men vaccinated
In November of 2008, Merck announced that it had completed a study of the efficacy of
using Gardasil to prevent genital lesions caused by HPV in men.   A spokesperson for Merck
51
told the media that an FDA approval process is presently underway.   While, like the studies of
52
Gardasil for women, the studies could not determine conclusively whether Gardasil was effective
in preventing cancer (here, anal and penile cancers) due to the length of time it takes from the
initial development of the HPV infection to the development of cancer, the clinical studies did
demonstrate that Gardasil was successful in preventing both the lesions and the infection.   Anna
53
Id., but see Judith Sites-Poisson, Women in Government, Merck’s Trojan Horse: Part
48
Three in a Series on the Politics and PR of Cervical Cancer, CENTER FOR MEDIA &
DEMOCRACY, July 10, 2007, http://prwatch.org/node/6232 (“Following the executive order,
allegations regarding connections between Perry and Merck became public, ‘It turned out that
Perry's former chief of staff is now a lobbyist for Merck. Did that look bad? Whoa, Nellie. Did it
look bad that Merck had funded an organization of women legislators backing similar bills?
Whoa, Merck.’”)
Nat’l Conference of State Legislatures, supra note 45.
49
Id., see also HPV Vaccine: Introduced Legislation 2008-2009
50
http://www.ncsl.org/programs/health/HPVvaccine.htm#2009leg (chart indicating state-by-state
legislative action regarding the vaccine).
Chitale, supra note 7.
51
Id.
52
Id.
53
9Guiliano, M.D., who led Merck’s study of the vaccine, affirmed the connection between the HPV
infection and cancers in men.
54
While not nearly as prevalent as cervical cancer, the National Cancer Institute reports that
1,200 new cases of penile cancer and 2,000 new cases of anal cancer are diagnosed annually in
men in the United States.   Giuliano says that 80-90% of those anal cancers and 40% of penile
55
cancers are a result of HPV.   For women, though, the connection between HPV and cervical
56
cancer is obvious. Women tend to see abnormal Pap smears between 2-4 years after becoming
infected, whereas men are unlikely to be diagnosed with penile or anal cancer until they are much
older- a typical diagnosis will occur between ages 50 and 80.   James Turner, M.D., professor of
57
clinical internal medicine at the University of Virginia and chair of the Vaccine Preventable
Disease Committee for the American College Health Association believes this will make
convincing men to get the vaccine more difficult.   Laurie Markowitz, an epidemiologist and
58
head of the CDC working group on HPV, does point out that there is already some interest in
Gardasil among select male populations- namely college-aged men and gay men.   This interest
59
could help spur lawmakers into making the vaccine mandatory for young men as well as women.
Part IV: Can/Should Gardasil be made mandatory for men?
Id.
54
Id.
55
Id.
56
Id. at 223.
57
Id.
58
Id.
59
10Just as Merck faced opposition when it introduced Gardasil for women onto the United
States market, it is likely to experience the same, if not more, when it begins to market Gardasil
for men.  It will likely have to overcome both legal and ethical concerns before it is able to gain
support for making the vaccine mandatory for all school children, both male and female.  The
legal opposition tends to come in the form of equal protection arguments.  While it may appear
as if the battle over whether vaccines can legally be made mandatory has already been fought and
won, there are several unique characteristics about HPV and Gardasil which make this fight a
slightly different one.  Ethical arguments against the vaccine being made mandatory for men
range from the idea that a vaccine for a sexually transmitted disease promotes promiscuity, to the
unfairness of making men get a vaccine for a disease that primarily effects women.  
A.  Legal Arguments
i.  Constitutional concerns
Opposition to state regulation of vaccines has generally stemmed from arguments that the
mandatory vaccinations violate the due process clause of the Constitution seen in the 14
th
Amendment.    Generally, states have been able to regulate the requirement of vaccines within
60
their states under their general “police powers.” While traditionally difficult to define,  a state
61
U.S. Const. amend. XIV. § 1., (“No State shall make or enforce any law which shall
60
abridge the privileges or immunities of citizens of the United States; nor shall any State deprive
any person of life, liberty, or property, without due process of law; nor deny to any person within
its jurisdiction the equal protection of the laws.”).
See e.g., Berman v. Parker, 348 U.S. 26 (1954), (Justice William O. Douglas explained,
61
“An attempt to define its reach or trace its outer limits is fruitless, for each case must turn on its
own facts.”); Jacobson v. Massachusetts, 197 U.S. 11, 25, (defining police power as “a power
which the state did not surrender when becoming a member of the Union under the
Constitution.”).
11derives its police powers from the Tenth Amendment.  The Tenth Amendment leaves the states
the power to regulate matters of health, safety and general welfare of the public.   
62
The Supreme Court first faced the question of whether requiring mandatory vaccinations
is a constitutional use of a state’s police power in Jacobson v. Massachusetts.  In Jacobson, a
Massachusetts citizen challenged a state law requiring citizens to be immunized for smallpox. 
There, the court defined the reach of the state’s police powers, explaining that, “[I]n every
well-ordered society charged with the duty of conserving the safety of its members, the rights of
the individual in respect of his liberty may at times, under the pressure of great dangers, be
subjected to such restraint, to be enforced by reasonable regulations, as the safety of the general
public may demand.”   The court further explained that mandatory vaccines are legal because,
63
“[t]here are manifold restraints to which every person is necessarily subject for the common
good.”   The Jacobson court upheld a state legislature’s decision that smallpox vaccines were
64
“necessary for the public health or public safety,” even where that decision was actually made by
an appointed board of health.   While the court did not go so far as to hold that medical
65
exemptions to mandatory vaccination laws were necessary, it did discuss that mandating
vaccinations for those who may have an adverse reaction to the vaccination would be “cruel and
inhuman to the last degree.”
66
Carrie A. Roll, The Human Papillomavirus Vaccine: Should it be Mandatory or
62
Voluntary?, 10 J. Health Care L. & Pol’y 421, 428-29 (2007).
Jacobson v. Massachusetts, 197 U.S. 11 at 29.
63
Id. at 26.
64
Id. at 27.
65
Id. at 38-39.
66
12The Court expanded the reach of Jacobson in Zucht v. King.   In Zucht, the court
67
expanded the police power to cover state orders requiring compulsory vaccination before a child
may attend school.  In defending compulsory vaccinations for schoolchildren, the court rejected
claims that these laws violated the equal protection clause because they targeted only school
children and not the entire population.  The court explained, however, that “[a] long line of
decisions by this court had also settled that in the exercise of the police power reasonable
classification may be freely applied, and that regulation is not violative of the equal protection
clause merely because it is not all-embracing.”  
68
The court rejected arguments that mandatory vaccination laws violate the First
Amendments right to practice religion freely in Prince v. Massachusetts.  The court explained
that, “[a]gainst these sacred private (religious) interests, basic in a democracy, stand the interests
of society to protect the welfare of children, and the state's assertion of authority to that end,
made here in a manner conceded valid if only secular things were involved.”   The Court further
69
reasoned that although parents may become martyrs acting against the state in matters of their
own health, that does not mean that they can choose to make martyrs of their children, since
these children have not yet reached the age where they are capable of making such a decision for
themselves.
70
Beyond due process concerns, some have argued that mandatory vaccinations violate a
Zucht v. King, 260 U.S. 174 (1922).
67
Id. at 176-77.
68
Id. at 165.
69
Prince v. Massachusetts, 321 U.S. 158, 170 (1944).
70
13different part of the 14  Amendment- the equal protection clause.  They argue that forcing only
th
women to be vaccinated for a disease which is spread by both men and women is unfair,
particularly since vaccines are successful only if they achieve “herd immunity,” meaning a level
of immunity which is high enough to prevent the disease from being spread at all.   Studies have
71
failed to reach a consensus as to what percent of a population must be vaccinated in order to
achieve “herd immunity,” but this percent typically ranges from 75% to 90% of the population.  
72
Even if 75% is a generous estimate, any percent over 50% would require men to be vaccinated if
herd immunity is to be achieved.   Thus, many argue that men should be vaccinated in order to
73
achieve this herd immunity, and to guarantee that statutes do not single out women unfairly in
violation of the Equal Protection Clause.  Doing so, however, would result in what has been
called a form of “reverse equal protection.”   The equal protection clause “cannot provide for an
74
artificial and fictional parity by having those who are not really equals or similarly circumstanced
become equals.”   Since the male and female biological makeup is so inherently different,
75
forcing men to get vaccinated in order to create so-called “fictional parity” may be illegal. 
In Adams v. Milwaukee, the court addressed a similar concern.   Adams upheld an
76
Nicki Daniels, Boys should be vaccinated too, The Times (U.K.), Oct. 27, 2006, at 10
71
(2006 WLNR 18651650).
Sylvia Law, Human Papillomavirus Vaccination, Private Choice, and Public Health, 41
72
U.C. Davis Law Review 1731, 1762 (June 2008).
See id.
73
RENE B. GOROSPE, CONSTITUTIONAL LAW: NOTES AND READINGS ON THE BILL OF
74
RIGHTS, CITIZENSHIP AND SUFFRAGE, 412 (Rex Bookstore, Inc. 2006).
Id.
75
Adams v. City of Milkwaukee, 228 U.S. 572 (1933).
76
14ordinance regulating the sale of milk which allegedly discriminated between milk drawn from
cows inside the city and those outside the city.  The court held that the regulations were not
discriminatory, since they were properly related to the purpose which the ordinance sought to
accomplish.   Since females are primarily affected by HPV through the development of cervical
77
cancer, so long as statutes are narrowly drawn and emphasize the need to prevent cervical cancer,
not the HPV infection generally, statutes which only mandate Gardasil for females are likely to
be upheld under equal protection challenges.
Despite the case law establishing the constitutionality of mandatory vaccination laws,
opponents of making Gardasil mandatory for women have pointed out that HPV is inherently
different from the diseases that the vaccines in the aforementioned cases were designed to
prevent.  Whereas smallpox or measles, both diseases traditionally covered by mandatory
78
school-entry vaccinations, are transmitted through the air, HPV is transmitted through sexual
contact.   Gail Javitt, J.D., a research scholar with the Berman Institute of Bioethics at Johns
79
Hopkins University further explains that, "This vaccine is different...in that your risk is
influenced by your behavior and is not equally distributed."  States may push back on these
80
arguments, however, by pointing to their ability to control sexually transmitted infections as part
Adams at 581-82.  See also Miller v. Wilson, 236 U.S. 373, 384 (1915) (“[The
77
legislature] is free to recognize degrees of harm, and it may confine its restrictions to those
classes . . . where the need is deemed to be clearest.”).
See Richard K. Zimmerman, Ethical Analysis of HPV Vaccine Policy Options, 24
78
Vaccine 4812, 4815 (2006).
Id.
79
Chitale, supra note 7.
80
15of their public health power.    Gardasil is also different in the sense that preventing an outbreak
81
of HPV has not been deemed a “medical necessity.”  Mandating Gardasil, however, while not a
medical necessity, may be a practical one.  If people do not choose to protect themselves by
taking adequate precautions against the disease, then “legally compelled immunization is the
only practical way to combat the disease effectively.”
82
ii.  Parental Concerns
Another legal barrier Merck will have to face when trying to convince lawmakers to make
Gardasil mandatory for men is the issue of informed consent.  In 1994, Senior Attorney Dave
Benor of the Office of General Counsel for the U.S. Department of Health and Human Services
acknowledged that for mandatory vaccines, “there is no opportunity for informed consent, given
that state law at federal urging requires that [children] take these vaccines.”   In Allison v.
83
Merck, a mother brought suit against Merck and her county Health District after her son allegedly
suffered from blindness, deafness, mental retardation, and other ills as a result of the measles,
mumps and rubella (MMR) vaccine.   In a footnote, the court explained that the mother “never
84
See e.g., Stadium Book & Video, Inc. v. Miami-Dade County, 2006 WL 2374740
81
(upholding state interest in regulating video stores in order to prohibit the spread of sexually
transmitted infections), Ex Parte Fowler, 184 P.2d 184 (1947) (upholding legislation authorizing
local health officers to examine those arrested for crimes vagrancy, prostitution, rape or other sex
crimes to determine if they are infected with venereal disease, as a valid exercise of police
power) (But note, these cases deal with quarantines, and not vaccinations). 
Note, Toward a Twentieth Century Jacobson v. Massachusetts, 121 HVLR 1820 (May
82
2008).
Kristine M. Severyn, Jacobson v. Massachusetts: Impact on Informed Consent and
83
Vaccine Policy, 5 J. Pharmacy & L. 249, 255 (1995-96) 
Allison v. Merck, 878 P.2d 948, 951 (Nev. 1994).
84
16had any real choice” when deciding whether to give her son the vaccine.   Courts have, however,
85
been willing to uphold cases where informed consent was seemingly lacking, based on the
information the vaccine manufacturer provided in its package insert, even though parents are not
often given the opportunity to read these inserts.  
86
Beyond informed consent concerns, parents may object to any attempts to make Gardasil
mandatory for men based on the more broad principle of parental choice.  The Supreme Court
has held that, “[t]he child is not the mere creature of the State; those who nurture him and direct
his destiny have the right, coupled with the high duty, to recognize and prepare him for additional
obligations.”   Courts have not had trouble holding that this right of parental choice may be
87
overridden when the child’s life is at stake, however they have been less apt to impose upon
parents medical treatments where the child’s life is not at stake.   While one could argue that a
88
child’s life may be at stake if they acquire HPV, there is no guarantee that they will acquire the
infection in the first place.  Instead, a court is likely to find that while certainly beneficial,
Gardasil is not in fact life-saving and thus states may not be able to override parental concerns in
mandating it.
89
Id. at FN9. (“Not only was she, let us say, “strongly encouraged” to make the decision to
85
go ahead with her child's vaccination, she was faced with the Hobson's choice of either having
the vaccine administered or not having the privilege of sending her son to private or public
school...Choosing not to have her son attend school, of course, would have subjected her to
criminal penalties unless she had the means to have her son educated at home.  Even if the
Allisons could be seen to have been properly warned of the risk inherent in this vaccine, it is hard
to conclude that they freely accepted the risk of the horrible injuries resulting in this case.”)
See Mazur v. Merck, 964 F.2d 1348, 1362 (3rd Cir. 1992).
86
 Pierce v. Soc’y of Sisters, 268 U.S. 510, 535 (1925).
87
Law, supra note 72 at 1767. 
88
Id.
89
17iii.  Opting out
States have satisfied concerns about parental choice by providing parents with broad opt-
out powers.  These opt-out provisions typically allow for parents to opt-out of immunizations for
medical or religious reasons.  By January of 1998, all states allowed for medical exemptions.   In
90
order to qualify for a medical exemption, most states require a letter or documentation from a
physician.   All states grant medical exemptions for children who have an allergy to the vaccine,
91
a compromised immune system, or a similar condition.   Opting out for religious reasons is the
92
easiest way for parents to avoid mandatory immunization laws.  Almost all states offer religious
exemptions to vaccinations, and a handful of states offer “philosophical exemptions” as well.  
93
These exemptions are granted virtually “on demand,”  however, each state defines its exemption
94
differently.  For example, in Texas, one must submit a letter from a faith leader, whereas in
California, all that is necessary is a parental affidavit.
95
While allowing parents to opt-out of vaccinations on behalf of their children may satisfy
parental choice concerns, some believe that opting out is dangerous for the rest of society.  A
Daniel A. Salmon et al., Health Consequences of Religious and Philosophical
90
Exemptions from Immunization Laws: Individual and Societal Risks of Measles, 282 Journal of
the American Medical Association 47, 47 (1999).
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Jason L. Schwartz, Commentary, Unintended Consequences: The Primacy of Public
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Trust in Vaccination, 107 Mich. L. Rev. First Impressions 100 (2009), http://
www.michiganlawreview.org/firstimpressions/vol107/schwartz.pdf.
Donald G. McNeil Jr., Worship Optional: Joining a Church to Avoid Vaccines, N.Y.
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TIMES, Jan. 14, 2003, at F1.
Id. (Noting that the American Journal of Public Health found in 2000 that only 21 of the
94
47 states had ever denied a request for a religious exemption).
Salmon, supra note 89 at 48.
95
18study done of data collected by the Measles Surveillance System of the CDC found that, on
average, exemptors were 35 times more likely to contract the disease than vaccinated
individuals.   The study concluded that the incidence of the measles infection would increase
96
greatly as the population of exemptors in a particular region increased.   Additionally, the last
97
two polio outbreaks in the United States took place in Amish and Mennonite communities during
the 1970s and similar measles outbreaks have occurred in Christian Science and Amish schools
in the 1980s.
98
b.  Ethical Arguments
Even if Gardasil were to surmount the legal barriers which are currently making it more
difficult for states to make it mandatory for men, there are a variety of ethical concerns that will
likely be raised as well, ranging from concerns about fairness to both male and female patients, to
questions about the correlation between the vaccination and promiscuous behavior, to concerns
about the cost and marketing of the drug.
i.  Questions of fairness
Similar to the concerns raised in the equal protection discussion above, many have argued
that only making Gardasil for female children in order to enter public schools is simply unfair to
those female children.  They point to the connection between HPV and sexual contact.   Even a
99
Id. at 47.
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Id. (“Specifically, the study found that if the number of exemptors doubled, the
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incidence of measles infection in nonexempt individuals would increase by 5.5%, 18.6%, and
30.8%, respectively, for intergroup mixing ratios of 20%, 40%, and 60%”).
McNeil, supra note 92.
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Daniels, supra note 71.
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19monogamous woman is at risk due to any of her partner’s previous sexual relationships.
100
While these concerns about fairness are legitimate, one must also consider: is it fair to
vaccinate men just to make things more “fair” for women?  Currently, the Gardasil vaccine
involves some degree of risk.  Primarily, the vaccine has not been around long enough to
determine its long term effects.  It is unclear as to whether the young age at which it is
administered will result in the need for booster shots later in life.   The FDA’s Patient
101
Information About Gardasil lists pain, swelling, itching, and redness at the injection site,
headache, fever, nausea, dizziness, vomiting, and fainting as the most common side effects of the
immunization.   While these may not be the most troublesome side effects, they are worth
102
considering when doing a cost-benefit analysis regarding whether giving Gardasil to men is
worth the risk.  Also important to consider are the less common, but more serious adverse events
that have been reported to the FDA following Gardasil injections.  Although Merck notes that
“[b]ecause these events were reported voluntarily from a population of uncertain size, it is not
possible to reliably estimate their frequency or to establish a causal relationship to vaccine
exposure,”  they are still worth considering when deciding whether males should be given the
103
Gardasil vaccine.  The more serious side effects reported have ranged from death, to autoimmune
disease, to paralysis and seizures.   Because of these side effects, the National Vaccine
104
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101
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20Information Center has been vocal in its opposition to the vaccine.   They report that there are
105
29 known cases of young patients dying after receiving the vaccine, based on the Vaccine
Adverse Events Reporting System compiled by the FDA.   Men may find that these risks
106
associated with the vaccine are too high to justify the benefit of the prevention of penile and anal
cancers, especially when those cancers occur infrequently.
iii.  Focusing only on gay men
Getting men vaccinated will also be difficult because doctors have hypothesized that it is
gay men who are most in need of the vaccine.   A study of men who seek male sexual partners
107
in Australia found that these men were strongly in favor of the vaccine.   However, it would be
108
difficult to target the vaccine only at the subset of the male population who seeks homosexual
partners.  Like only giving the vaccine to girls, it seems unfair to only give the vaccine to
homosexual men.  If heterosexual men are carriers as well, one could argue that they should be
equally encouraged to be vaccinated.  Only advocating that homosexual men become vaccinated
is also problematic because doctors encourage vaccination before one’s sexual debut.   Males
109
between ages 9-11, the age when Gardasil is recommended to be given to females, are unlikely to
be comfortable talking to their doctor about their sexual preferences, so it will be very difficult
Post of Erin Brown to NewsBusters.com blog, Post Article Largely Ignores Health
105
Problems With Gardasil Vaccine,
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21for doctors to ascertain whether one male should get the vaccine over another. 
iii.  Promotion of promiscuity
Perhaps the greatest ethical opposition Gardasil for men will face, like Gardasil for
women, is the argument that a vaccination for a sexually transmitted disease will promote
promiscuity in young teenagers.   Some fear that the vaccine will encourage more sexual
110
activity among partners, increased numbers of partners, and less use of other forms of
protection.   This may result in more unplanned pregnancies, abortions, and other forms of
111
sexually transmitted infections.   Opponents fear that the vaccine may send the message, 'We
112
expect you to be sexually active,' to teens said Reginald Finger, a doctor trained in public health
who served as a medical analyst for Focus on the Family.   A state representative in California
113
went so far as to say that the money spent on Gardasil should be spent on other vaccines-
emphasizing that cervical cancer involves a lifestyle choice, whereas other cancers are a result of
unlucky genetics.   Some believe that such concerns about promiscuity (as well as parents
114
beliefs that their children will remain abstinent until marriage) will cause many parents to oppose
the vaccine.
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31, 2005, at A3.
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SLATE, September 27, 2007, http://www.slate.com/id/2174850/.
See R. Alta Charo, Politics, Parents, and Prophylaxis--Mandating HPV Vaccination in
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the United States, 356 New Eng. J. Med. 1905, 1907 (2007).
22Despite this opposition by parents who believe their children will not become sexually
active and thus advocate abstinence-only sex education rather than the vaccine, studies have
shown that abstinence programs do not delay the onset of sexual activity in teenagers, nor do they
reduce the number of sexual encounters that these teenagers will engage in.   Studies regarding
116
condom availability have similar results.  Adolescents who are provided with condoms are no
more likely to engage in more sexually activity as a result than those who were not provided with
condoms.   Others have emphasized that it is improbable that HPV will be a significant
117
deterrent for teenage sexual behavior.  Whereas STDs like herpes or gonorrhea have immediate
effects, the effects of HPV are so far removed from the sexual activity itself that teenagers are
unlikely to make the connection between the vaccination and the ability to have more sexual
encounters without risk.   It is also important to note that the vaccinations are not given to
118
young adults merely to prevent the spread of HPV amongst that age group.  Vaccinations are
meant to have life-long effects, and vaccinating eleven to fourteen year olds may simply be the
most efficient way to achieve these life-long effects.
119
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Ann Quigley, School Condom Availability Does Not Increase Sexual Activity, CTR.
117
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http://www.hbns.org/news/condom05-28-03.cfm. (However, the condom availability did result in
those teenagers who were already engaging in sexually conduct becoming more likely to use
those condoms). 
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See Cynthia Dailard, Achieving Universal Vaccination Against Cervical Cancer in the
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United States: The Need and the Means, 9 Guttmacher Pol’y Rev. 12, 14 (2006), see also James
G. Hodge, Jr. & Lawrence O. Gostin, School Vaccination Requirements:
Historical, Social, and Legal Perspectives, 90 KY. L.J. 831, 869-73 (2002) (discussing rubella
and hepatis B vaccinations as examples of vaccinations given to children whose effects are often
not seen until later in life). 
23Approximately 80 percent of deaths from cervical cancer worldwide occur outside the
United States,  where arguments connecting Gardasil with promiscuity will most likely have a
120
greater impact.   In countries where discussing female sexual behavior is more taboo, some
suggest that it may in fact be easier to have boys vaccinated than girls.   Anne Szarewski, of
121
from the charity Cancer Research UK notes that, "We found that some Asian women in Britain
are afraid even to get tested for HPV infection, because they say if it is positive they will be
killed, never mind that their husbands probably gave it to them.”
122
An alternative to Gardasil which may be able to surmount the opposition based on a fear
of promoting promiscuity is the yet-to-be-approved Cervarix vaccine, currently being developed
by GlaxoSmithKline.   Unlike Gardasil, Cervarix will not prevent genital warts.   Since it is
123 124
focused solely on preventing cervical cancer, GlaxoSmithKline hopes it will be able deflect some
of the criticism from those who fear Gardasil will defeat their efforts to promote abstinence.  
125
Unfortunately for GlaxoSmithKline, however, by the time its vaccine reaches the market,
Gardasil will have already been alone in the market for approximately 16 to 19 months or more,
Debora MacKenzie, Will Cancer Vaccine Get to All Women?, NewScientist, Apr. 18,
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ml (last visited Mar. 29, 2009).
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24depending on the FDA approval process.
126
Marketing Gardasil to men may receive less criticism based on concerns about
promiscuity as marketing it to women did.  Susan M. Reverby, a professor of women's studies
and medical history at Wellesley College, points out that, “We are still more worried about the
promiscuity of girls than the promiscuity of boys.”   The debate surrounding Gardasil for men
127
has already focused more attention on issues such as the vaccine’s cost and the risks associated
with administering it, rather than promiscuity, when compared to the debate that occurred when
the vaccine was introduced for women.   Only time will tell if this bias will continue following
128
FDA and CDC approval of the vaccine for men.
iv.  Cost
It may also be difficult to get men vaccinated against the HPV virus because the current
cost of Gardasil is prohibitively high for some.  Currently, the vaccine costs approximately $360
for the necessary three doses.   Unfortunately, the age group which would receive the most
129
benefit from the vaccine, eleven to fourteen year olds, are the least likely to be able to afford the
vaccine.   Whereas infants born in hospitals are likely to receive proper health care and
130
vaccinations due to the hospitals standards of care, and older teenagers are able to get health care
from family planning clinics, the eleven to fourteen year olds who have the most to benefit from
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25the vaccine may not have regular visits to a health care provider.   Even those with private
131
health insurance may have a hard time paying for the vaccine, due to prohibitively high co-
payments and deductible costs,  and the number of insurance providers refusing to cover to the
132
costs of vaccinations.
133
Gardasil’s high cost  has led some to question whether men should be asked to bear the
burden for the cost of women’s health.  While some seem open to the idea,  the significantly 
134
lower cancer rates among males who have contracted HPV may be too low to justify the cost for
most men, especially when cheaper alternatives such as condoms, abstinence and male
circumcision are available to at-risk groups.   However, assuming the vaccine is recommended
135
by ACIP for men as it has been for women, those who can not afford the vaccine on their own
may receive public funding.  Both Medicaid, and the federally-funded VCF Program may cover
the vaccine along with all other ACIP-approved vaccinations for individuals under 21 who
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_APR_JUN_Article_1.pdf.
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Insurance Products, 119 Pediatrics 622, 622 (2007) (From 2003 to 2006, the number of
employee sponsored plans which did not cover vaccinations increased from 5% to 20%).
Jan Hoffman, Vaccinating Boys for Girls’ Sake?, N.Y. TIMES, Feb. 24, 2008, available
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at 2008 WLNR 3619620, (“That’s good enough for some mothers. “If there was a vaccine I
could take that would get rid of prostate cancer, why wouldn’t I?” said Lisa Lippman, a
Manhattan real estate broker with three sons. “If there was a vaccine that sons could get that
would get rid of breast cancer, most parents wouldn’t hesitate. But cervical cancer is the ‘sex
cancer.’ ”)
See Roden & Wu, supra note 20, at 761.
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26qualify for the programs.   However, the states are often asked to bear the burden of these
136
federally mandated health programs, and it is unlikely that most states will have the funding to
cover such a high volume of vaccinations.   Inclusion in these programs may also give private
137
insurance companies an excuse not to cover the shots, since they will assume the states will cover
them.
138
A large-scale cost-benefit analysis may still reveal that the vaccine is worth its cost when
examined alongside overall healthcare costs.  Currently, the HPV infection amounts to
somewhere between $2.25 and $4.6 billion in healthcare costs per year.   However, since
139
Gardasil does not cover all types of HPV, it may be important to continue the costly screening
process already in place, thus reducing some of the positive cost-reducing effects of the
vaccine.   
140
v.  Marketing
While Merck has been hugely successful in marketing the vaccine to women,  that same
141
success may ultimately be its biggest hurdle in getting men interested in becoming vaccinated. 
Roll, supra note 62, at 441-42 (The Vaccines for Children Program applies to children
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18 and under who are: (1) Medicaid eligible; (2) uninsured; (3) underinsured; or 4) Native
American or Alaska Natives.). 
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27To market Gardasil, Merck garnered the help of public relations superstar Edelman.   Edelman
142
is the world’s largest independent public relations firm; they generated $299 million in revenues
in 2006.   Edelman is known for its role in creating partnerships between business and non-
143
profits, and it has worked with the tobacco industry, companies facing environmental disasters,
and most of the world’s largest pharmaceutical companies.   Their work for Merck has garnered
144
the company numerous accolades- they received the Public Health Award at the PhAME Awards
(“the first and most comprehensive awards ceremony focusing on pharmaceutical consumer
marketing and communications”), and the website Pharmaceutical Executive Magazine selected
Gardasil as its brand of the year.
145
Gardasil’s advertisements have been aimed solely at young women and their mothers, and
its “one less”campaign seemed to be everywhere.   For several months, it was difficult to turn
146
on the television and not run into female skateboarders and jump-ropers chanting “O-N-E-L-E-S-
S.  I want to be one less. One less.”  
Despite the campaign’s success among advertising industry professionals, it may
ultimately backfire. “[Parents] didn’t see it as having much benefit for their sons,” said Dr.
Kharbanda, an adolescent specialist at New York-Presbyterian/Columbia University Medical
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28Center. “It was smart of Merck to get people excited about it for the girls, but now they’re stuck
with that perception.”   Merck may have an especially difficult time encouraging men to get
147
vaccinated since its advertisements have made a point of avoiding all discussion of the
connection between Gardasil and genital warts.   The lack of understanding of that connection,
148
combined with the significantly lower number of instances of anal and penile cancers in men as a
result of the HPV infection and Merck’s advertisements which have made Gardasil a “girl’s
vaccine” will make it difficult for them to garner the same degree of hype to get men vaccinated
as it did for women.
vi.  Anti-vaccination trend
Finally, there is a growing trend of parental opposition to all vaccines generally which
will likely play a role in preventing men from choosing to be vaccinated against HPV.  This
trend, led by well-known public figures such as Congressman Dan Burton, Robert F. Kennedy Jr.
and actress Jenny McCarthy, has emphasized speculations regarding a possible link between
vaccinations and diseases such as autism.   These arguments typically gain force due to the
149
present low instances of diseases such as polio or measles which children are typically vaccinated
against.  Health officials emphasize, however, that continued vaccination is the only way to
continue to keep these diseases at bay.   
150
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29Organizations such as the Anti-Vaccination League of America are growing as well. 
Groups like these tend to have two main reasons for opposing vaccinations: some believe that
mandatory vaccinations amount to a sort of “medical tyranny,” similar to religious or political
tyranny, while others believe that vaccinations prevent health risks which are much greater than
the FDA and the pharmaceutical industry wants us to believe.   Those that believe mandatory
151
vaccinations are a form of medical tyranny point to the fact that the European countries with the
highest levels of immunization have reached those levels without making vaccines mandatory.  
152
This argument may not have much force.  The United States differs from these European
countries in two significant respects: (1) the United States lacks a comprehensive healthcare
system, and (2) the United Stats lack universal health insurance.  
153
Part V: What should be done? 
As a result of these barriers, Merck will have several options when it officially begins to
market the Gardasil vaccine to men.  First, it may seek to encourage state and federal legislators
to treat both men and women the same for vaccination purposes, requiring the vaccine before
school entry for all children, not just females.  Alternatively, if this proves to be too burdensome,
based on equal protection and due process concerns, they may be better off simply educating and
incentivizing men to get vaccinated, without going so far as to make it mandatory.  Taking this
See Note, supra note 83, at 1823.
151
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30route appears as if it will be the more successful although less lucrative one, as it will allow
Merck to tailor its message to men differently than it has for women, and will allow it to focus on
the most at-risk subset of the male population, homosexual men.
31